Total Ankle Replacement: What It Is, Who Needs It, and What to Expect

Ankle arthritis is a profoundly limiting condition. Unlike hip or knee arthritis — which restricts movement that can often be partially compensated — severe ankle arthritis makes every step painful, affects balance, and cascades up the kinetic chain to create secondary knee and hip problems. When conservative care has been exhausted, patients face a fundamental choice: ankle fusion (arthrodesis) or total ankle replacement (arthroplasty). The choice used to be straightforward — fusion was the gold standard. In 2026, that calculus has changed significantly, and for the right patient, total ankle replacement offers a restoration of ankle motion and long-term function that fusion simply cannot provide.

What Is Total Ankle Replacement?

Total ankle replacement (TAR) — also called total ankle arthroplasty — is a surgical procedure that replaces the arthritic joint surfaces of the tibiotalar (ankle) joint with metal and ultra-high-molecular-weight polyethylene implants. The procedure removes the damaged cartilage and subchondral bone from both the tibia (lower leg) and talus (the ankle bone), replacing them with prosthetic surfaces that allow the joint to continue moving while eliminating the bone-on-bone contact that causes pain.

The tibial component (titanium or cobalt-chrome alloy) attaches to the distal tibia. The talar component attaches to the talus. A mobile or fixed polyethylene bearing sits between the two metal surfaces, providing articulation. The ligamentous structures and tendons of the ankle are preserved — a critical difference from fusion, where everything is immobilized.

Total Ankle Replacement vs. Ankle Fusion: How to Choose

The choice between TAR and ankle fusion is one of the most important decisions in ankle surgery — and it is highly individualized. Here is how we approach the decision at Balance Foot & Ankle:

Factors Favoring Total Ankle Replacement

• Age over 55 (lower-demand lifestyle reduces implant wear rate)
• Normal or near-normal ankle alignment (coronal deformity <15°)
• Adequate bone stock for implant fixation (no severe osteoporosis or large cysts)
• Bilateral ankle arthritis (fusion of both ankles severely impairs gait)
• Ipsilateral subtalar or midtarsal arthritis (fusion would create excessively rigid foot complex)
• Prior ipsilateral hip or knee fusion (preserving ankle motion is critical for overall function)
• Patient desire to maintain motion for activities of daily living

Factors Favoring Ankle Fusion

• Young, high-demand patients (under 50) who place high mechanical loads on the ankle
• Significant coronal deformity (>15° varus or valgus) — poor outcomes with TAR without correction
• Severe bone loss or avascular necrosis of the talus
• Active infection or prior septic arthritis
• Significant peripheral vascular disease (compromises healing around implant)
• Severe obesity (BMI >40 substantially increases implant failure risk)
• Neurological conditions affecting the ankle (Charcot neuropathic arthropathy — relative contraindication)

Causes of Ankle Arthritis Leading to Replacement

Unlike hip and knee arthritis — which is predominantly primary osteoarthritis — ankle arthritis is post-traumatic in 70–80% of cases. The most common causes:

• Post-traumatic arthritis: Previous ankle fracture (particularly bimalleolar or trimalleolar fractures), talar dome osteochondral defects, or severe ankle sprains with chronic instability causing cartilage damage over years.
• Rheumatoid arthritis: Inflammatory arthritis affecting all three ankle joint compartments simultaneously, often in combination with hindfoot involvement.
• Hemophilic arthropathy: Recurrent intra-articular hemorrhage causing cartilage destruction.
• Primary osteoarthritis: Less common than at hip or knee, but occurs — particularly in patients with malalignment or a long history of high-impact activity.
• Osteonecrosis / avascular necrosis: Talar body AVN from trauma or corticosteroid use.

Modern Ankle Replacement Implants: Third-Generation Systems

Early (first and second generation) ankle replacement implants had 5-year survival rates of 60–70% and fell out of favor by the 1990s. Third-generation implants — introduced in the early 2000s and continuously refined — have transformed the procedure’s outcomes. Current FDA-approved third-generation systems include:

• STAR (Scandinavian Total Ankle Replacement): The most extensively studied system, with 15+ year follow-up data. Mobile-bearing design. 10-year survivorship 80–90% in the published literature.
• INBONE / INFINITY (Wright Medical): Intramedullary tibial stem fixation providing excellent initial stability. Particularly useful in revision settings or with tibial deformity. Fixed-bearing design.
• Salto Talaris: Fixed-bearing anatomic design with strong 10-year data. Less technically demanding approach than some competitors.
• VANTAGE (Exactech): Newer system with enhanced bone-sparing design and improved instrumentation accuracy. Growing evidence base.
• Zimmer Biomet Trabecular Metal TAA: Uses porous trabecular metal for superior osseointegration.

Published 10-year survivorship for third-generation implants ranges from 80–92% in high-volume centers, with some studies reporting 15-year survivorship approaching 80%. These figures compare favorably with hip and knee arthroplasty outcomes from 20–25 years ago, and improvement continues with each design iteration.

What the Surgery Involves

Total ankle replacement is performed under general or spinal anesthesia, typically as an outpatient or one-night stay. The anterior approach — through the front of the ankle — is most common. The extensor tendons and neurovascular structures are carefully retracted while the ankle joint is exposed. The arthritic surfaces are precisely resected using system-specific cutting guides, typically removing 8–12mm of bone from the distal tibia and talus. Implant components are then press-fit (and in some systems, cemented) into position. The polyethylene bearing is seated between the metal components. Wound closure, splint application, and non-weight-bearing positioning complete the procedure. Total operative time: 1.5–2.5 hours.

Recovery After Total Ankle Replacement

Recovery from TAR is longer and more demanding than many patients expect. Here is a realistic timeline:

• 0–2 weeks: Non-weight-bearing in a splint or cast. Significant post-operative swelling and pain managed with elevation, ice, and prescribed analgesia. Thromboprophylaxis (blood clot prevention) is standard.
• 2–6 weeks: Progressive weight-bearing in a walking cast or CAM boot, depending on implant stability and bone quality. Physical therapy begins: range-of-motion exercises, edema management, proprioceptive retraining.
• 6–12 weeks: Transition to regular footwear (with custom orthotics). Continued PT focusing on ankle strength, range of motion, and gait retraining. Most patients walk without assistive devices by 8–10 weeks.
• 3–6 months: Return to light recreational activities. Swelling typically resolves significantly. Range of motion continues to improve. Most patients reach 90%+ of final function by 6 months.
• 6–12 months: Return to low-impact sport (cycling, swimming, golf). Full range of motion and maximum function typically achieved at 12 months. Impact sports (running, tennis) may be permitted in appropriate patients after surgeon clearance.

Risks and Complications

Total ankle replacement carries specific risks that patients must understand before consenting to surgery:

• Wound healing complications: The anterior ankle has relatively poor soft-tissue coverage. Wound dehiscence and superficial infection occur in 5–10% of cases; deep infection (periprosthetic joint infection) in 1–2%. Smoking and diabetes significantly increase this risk.
• Implant loosening / failure: The primary cause of revision surgery, typically occurring at 10+ years. Fixed-bearing components tend to loosen at the tibial component; mobile-bearing components can develop bearing dislocation.
• Periprosthetic fracture: Fracture around the implant, particularly at the malleoli during surgery or postoperatively.
• Subsidence: The talar component sinking into the talus due to poor bone quality. More common in osteoporotic patients and those with large subchondral cysts.
• Nerve or tendon injury: The superficial peroneal nerve and extensor tendons are at risk during the anterior approach. Experienced surgeons have very low rates (<1%).
• Deep vein thrombosis / pulmonary embolism: Standard anticoagulation protocols have reduced this risk substantially.

Conservative Care Before Considering Replacement

Surgery is appropriate only after structured conservative care has been genuinely and consistently pursued. Before recommending TAR or fusion at Balance Foot & Ankle, we require documentation of:

• Appropriate footwear: Stiff-soled rocker shoes that minimize tibiotalar motion and reduce pain during walking. Arizona brace or custom AFO for severe cases.
• Physical therapy: Peroneal and tibialis anterior strengthening, proprioceptive training, aquatic therapy for offloading.
• Weight management: BMI reduction toward target if elevated — significant effect on both conservative outcomes and surgical risk.
• Intra-articular corticosteroid injection: Provides 2–6 months of relief for many patients and can defer surgery for years with repeated use. Limit to 3–4 per year to avoid cartilage and tendon effects.
• Viscosupplementation (hyaluronic acid injection): Less evidence than in knee, but some patients with early-moderate ankle arthritis benefit.
• Regenerative options: Platelet-rich plasma (PRP) and bone marrow aspirate concentrate (BMAC) are being studied for early-moderate ankle arthritis; evidence is emerging but not yet definitive.

The Most Common Mistake We See

The most common mistake is proceeding to surgery without exhausting conservative care — specifically without a structured physical therapy program and a trial of appropriate bracing. We see patients referred for surgery who have had ankle arthritis for 2 years but have never worn a properly fitted custom AFO or undergone a targeted ankle-strengthening program. These interventions can provide meaningful pain relief for 3–5 years in many patients. Surgery performed prematurely not only risks the surgical complications above — it starts the implant’s wear clock earlier, increasing the probability that a revision will be needed in the patient’s lifetime.

Frequently Asked Questions

How long does a total ankle replacement last?
Third-generation implants achieve 80–90% survivorship at 10 years and approximately 70–80% at 15 years in published series from high-volume centers. These figures continue to improve as implant design, instrumentation, and surgical technique advance. Patients implanted today are likely to see better long-term results than the published historical data suggests.

Can a failed ankle replacement be revised?
Yes — revision TAR or conversion to ankle fusion are both options for failed primary TAR. Revision surgery is technically demanding and outcomes are less predictable than primary replacement, which is why appropriate patient selection for the index procedure is so critical. In the hands of experienced revision surgeons, good functional outcomes are achievable.

Is ankle replacement covered by insurance?
Yes. Total ankle replacement is covered by most major insurance plans and Medicare when appropriately documented medical necessity criteria are met — end-stage ankle arthritis with radiographic evidence, functional limitation, and documented failure of conservative care. Our office handles insurance pre-authorization.

Can I run after total ankle replacement?
Low-impact running may be permitted by some surgeons in select patients (typically younger, higher-demand patients with excellent implant fixation) after 12–18 months. High-impact running is generally not recommended because it accelerates polyethylene wear. Cycling, swimming, golf, and low-impact aerobics are the most commonly recommended activities post-TAR.

What is the difference between ankle replacement and ankle fusion for pain relief?
Both procedures achieve excellent pain relief in appropriately selected patients — multiple comparative studies show similar VAS pain scores at 2-year follow-up. The meaningful difference is in function: TAR patients consistently demonstrate better gait mechanics, better stair negotiation, and better patient-reported activity scores than fusion patients at 5+ year follow-up.

The Bottom Line

Total ankle replacement has matured into a reliable, evidence-based surgical option for end-stage ankle arthritis in appropriate patients. Modern third-generation implants provide 10-year survivorship rates that compare favorably with early hip and knee replacement data — and outcomes are continuing to improve. The decision between TAR and ankle fusion requires careful individualized assessment of age, activity demands, alignment, bone quality, and adjacent joint status. At Balance Foot & Ankle, we take this decision seriously — and we always exhaust conservative options before recommending surgery. If you have end-stage ankle arthritis and want to understand your options, call us for a consultation.

Sources

• Slobogean GP, et al. “Total ankle arthroplasty: a systematic review.” Can J Surg. 2010;53(3):182-190.
• Daniels TR, et al. “Intermediate-term results of total ankle replacement and ankle arthrodesis.” J Bone Joint Surg Am. 2014;96(12):981-989.
• Veljkovic AN, et al. “Outcomes following total ankle replacement with the Scandinavian Total Ankle Replacement (STAR): a prospective study.” J Bone Joint Surg Am. 2019;101(17):1624-1633.